In an adult with a COPD exacerbation in the emergency department triggered by an upper‑respiratory infection, what systemic corticosteroid dose and route should be given, and which antibiotics should be prescribed?

COPD Exacerbation in the ER: Steroid and Antibiotic Management

Give oral prednisone 40 mg daily for 5 days and prescribe antibiotics (amoxicillin-clavulanate, doxycycline, or a macrolide based on local resistance patterns) for 5-7 days, especially if the patient has purulent sputum. 1, 2

Corticosteroid Therapy

Dose and Duration

The evidence strongly supports 40 mg oral prednisone daily for 5 days as the optimal regimen 1, 2. This recommendation comes from the 2017 GOLD guidelines and ERS/ATS guidelines, which demonstrate that this short-course, moderate-dose approach:

• Shortens recovery time
• Improves lung function (FEV1) and oxygenation
• Reduces risk of early relapse and treatment failure
• Decreases length of hospitalization 2

Key point: Longer courses (>5-7 days) provide no additional benefit and increase adverse effects 2, 3. Higher doses similarly offer no advantage over 40 mg daily 4, 5.

Route of Administration

Use the oral route unless the patient cannot tolerate oral medications. The evidence is clear that oral and IV corticosteroids are equally effective for COPD exacerbations 1.

Two trials involving 250 hospitalized patients showed:

• No difference in treatment failure (53.5% IV vs 49.6% oral)
• No difference in mortality (5.5% IV vs 1.7% oral)
• No difference in hospital readmissions or length of stay
• IV route had MORE adverse effects (70% vs 20% in one trial) 1

A large cohort study of nearly 80,000 patients confirmed oral steroids were not inferior to IV, with lower costs and shorter hospital stays 6.

Antibiotic Therapy

When to Prescribe

Antibiotics are indicated for this URI-triggered exacerbation 1, 2. The ERS/ATS guidelines recommend antibiotics for ambulatory COPD exacerbations with moderate-quality evidence, showing:

• 46% reduction in treatment failure
• 73-day longer time to next exacerbation
• Reduced mortality in hospitalized patients (78% reduction) 1, 7

Which Antibiotic

First-line options (choose based on local resistance patterns): 1, 2

• Amoxicillin-clavulanate (most commonly studied)
• Doxycycline
• Macrolide (azithromycin or clarithromycin)

The choice should be guided by local bacterial resistance patterns 1, 2. Studies used these agents for 7-10 days with similar efficacy 1.

Duration

5-7 days of antibiotic therapy is recommended 2. This duration balances efficacy with minimizing resistance and adverse effects.

Clinical Decision Points

Purulent Sputum

While antibiotics benefit most COPD exacerbations, the presence of purulent sputum is the strongest predictor of benefit 1, 2. However, given this is an ER presentation with URI trigger, antibiotics are still recommended even without documented purulence.

Common Pitfalls to Avoid

1. Don't use IV steroids reflexively – oral is equally effective and has fewer side effects
2. Don't extend steroid course beyond 5 days – no added benefit, more hyperglycemia risk
3. Don't use high-dose steroids – 40 mg is sufficient; higher doses increase adverse effects without improving outcomes
4. Don't skip antibiotics – they reduce treatment failure by nearly half 1

Monitoring

Watch for hyperglycemia – the most common steroid-related adverse effect, with a 2.8-fold increased risk 2, 3. Check blood glucose in diabetic patients or those at risk.

Special Consideration

If the patient has frequent exacerbations or severe airflow limitation, consider obtaining sputum cultures to identify resistant pathogens before selecting antibiotics 2.